Stockreport

Theratechnologies reports promising results from two peptide-drug conjugates [Seeking Alpha]

Theratechnologies Inc. - Common Shares  (THTX) 
PDF Theratechnologies (NASDAQ:THTXannouncesTH1902 (docetaxel peptide conjugate) and TH1904 (doxorubicin peptide conjugate) are more effective and better tolerated in animal [Read more]